The progress in the therapy of chronic myeloid leukemia

Journal Title: Postępy Nauk Medycznych - Year 2011, Vol 24, Issue 6

Abstract

The review describes current standards of chronic myeloid leukemia (CML) treatment. Recommendation of European LeukemiaNET for CML treatment are presented. In most patients as a first line treatment in newly diagnosed CML , imatinib since several years is the treatment of choice. Recommendation of second line treatment in case treatment failure are presented. In These cases second generation of tyrosine kinase inhibitors – dasatinib and nilotinib are the most preferred drugs. Indications for allogenic bone marrow transplantation for the resistant patients are also presented. Besides, new trends – which are at the stage of clinical trials aimed to cure the disease are presented.

Authors and Affiliations

Witold Prejzner, Andrzej Hellmann

Keywords

Related Articles

Hemoglobinopathies and thalasemias – genetic basis and molecular diagnosis

Hemoglobinopathies and thalasemias are genetic disorders connected with the presence of mutations in genes coding globin proteins, mainly in genes coding α and β globin. Hemoglobinopathies are...

Occurrence of minor histocompatibility antigens’ disparities in allogeneic hematopoietic stem cell transplantation recipients and their HLA-matched siblings

We have determined the alleles of eleven minor histocompatibility antigens (mHAgs) and investigated the occurrence of immunogenic mHAgs mismatches between a donor and a recipient of allogeneic hematopoietic stem cell tra...

Późna diagnoza hiperoksalurii u chorej po przeszczepieniu nerki – opis przypadku

Pierwotna hiperoksaluria (PH) jest rzadką chorobą genetyczną prowadzącą do zwiększonego wydalania szczawianów wapnia oraz ich odkładania się w tkankach. Pierwsze objawy zazwyczaj pojawiają się poniżej 5. roku życia i obe...

The role of hepcidin in inflammation

The recent discovery of hepcidin has significantly intensified research on iron metabolism. Hepcidin, which inhibits iron intake and release from cells, has turned out to be a crucial player in the mechanisms of iron abs...

Osteoporosis from a traumatologist’s point of view

According to contemporary definition osteoporosis is a condition characterized by reduced quality of bone tissue and resulting increase of fracture risk. Low-energy fractures are common in the population of patients over...

Download PDF file
  • EP ID EP54201
  • DOI -
  • Views 115
  • Downloads 0

How To Cite

Witold Prejzner, Andrzej Hellmann (2011). The progress in the therapy of chronic myeloid leukemia. Postępy Nauk Medycznych, 24(6), -. https://europub.co.uk/articles/-A-54201